Global In Situ Hybridization (ISH) Market 2021-2025

世界のIn situハイブリダイゼーション(ISH)市場2021-2025:FISH、CISH

◆タイトル:Global In Situ Hybridization (ISH) Market 2021-2025
◆商品コード:IRTNTR40880
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2021年4月14日
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

テクナビオ社は世界のIn situハイブリダイゼーション(ISH)市場規模が、2021年~2025年まで年平均7%成長し、475.05百万ドルに達すると予測しています。本調査レポートでは、世界のIn situハイブリダイゼーション(ISH)市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、技術別(FISH、CISH)分析、エンドユーザー別(分子診断研究所、製薬・バイオテクノロジー企業、その他)分析、顧客状況、地域別状況、企業状況、企業分析など、以下の構成でまとめております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のIn situハイブリダイゼーション(ISH)市場規模:技術別(FISH、CISH)
・世界のIn situハイブリダイゼーション(ISH)市場規模:エンドユーザー別(分子診断研究所、製薬・バイオテクノロジー企業、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析

Global In Situ Hybridization (ISH) Market 2021-2025
Technavio has been monitoring the in situ hybridization (ISH) market and it is poised to grow by $ 475.05 mn during 2021-2025, progressing at a CAGR of about 7% during the forecast period. Our report on in situ hybridization (ISH) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing demand for companion diagnostic tests and product launches. In addition, increasing demand for companion diagnostic tests is anticipated to boost the growth of the market as well.

The in situ hybridization (ISH) market analysis includes technology segment, end-user segment, and geographic landscape.

Technavio’s in situ hybridization (ISH) market is segmented as below:
By Technology
• FISH
• CISH

By End-user
• Molecular diagnostic laboratories
• Pharmaceutical and biotechnological companies
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• ROW

This study identifies the growing incidence and prevalence of cancer as one of the prime reasons driving the in situ hybridization (ISH) market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on in situ hybridization (ISH) market covers the following areas:
• In situ hybridization (ISH) market sizing
• In situ hybridization (ISH) market forecast
• In situ hybridization (ISH) market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in situ hybridization (ISH) market vendors that include Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the in situ hybridization (ISH) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/in-situ-hybridization-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【資料の目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Technology
 Market segments
 Comparison by Technology
 FISH – Market size and forecast 2020-2025
 CISH – Market size and forecast 2020-2025
 COVID-19 impact and recovery for technology segment
 Market opportunity by Technology
• Market Segmentation by End-user
 Market segments
 Comparison by End user
 Molecular diagnostic laboratories – Market size and forecast 2020-2025
 Pharmaceutical and biotechnological companies – Market size and forecast 2020-2025
 Others – Market size and forecast 2020-2025
 COVID-19 impact and recovery for end-user segment
 Market opportunity by End user
• Customer landscape
• Geographic Landscape
 Geographic segmentation
 Geographic comparison
 North America – Market size and forecast 2020-2025
 Europe – Market size and forecast 2020-2025
 Asia – Market size and forecast 2020-2025
 ROW – Market size and forecast 2020-2025
 Key leading countries
 Market opportunity by geography
 Market drivers
 Market challenges
 Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
o Industry risks
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Agilent Technologies Inc.
o Bio-Rad Laboratories Inc.
o Bio-Techne Corp.
o F. Hoffmann-La Roche Ltd.
o Merck KGaA
o PerkinElmer Inc.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2020 – 2025 ($ million)
• 14: Global market: Year-over-year growth 2020 – 2025 (%)
• 15: Five forces analysis 2020 & 2025
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2020
• 22: Technology – Market share 2020-2025 (%)
• 23: Comparison by Technology
• 24: FISH – Market size and forecast 2020-2025 ($ million)
• 25: FISH – Year-over-year growth 2020-2025 (%)
• 26: CISH – Market size and forecast 2020-2025 ($ million)
• 27: CISH – Year-over-year growth 2020-2025 (%)
• 28: Market opportunity by Technology
• 29: End user – Market share 2020-2025 (%)
• 30: Comparison by End user
• 31: Molecular diagnostic laboratories – Market size and forecast 2020-2025 ($ million)
• 32: Molecular diagnostic laboratories – Year-over-year growth 2020-2025 (%)
• 33: Pharmaceutical and biotechnological companies – Market size and forecast 2020-2025 ($ million)
• 34: Pharmaceutical and biotechnological companies – Year-over-year growth 2020-2025 (%)
• 35: Others – Market size and forecast 2020-2025 ($ million)
• 36: Others – Year-over-year growth 2020-2025 (%)
• 37: Market opportunity by End user
• 38: Customer landscape
• 39: Market share by geography 2020-2025 (%)
• 40: Geographic comparison
• 41: North America – Market size and forecast 2020-2025 ($ million)
• 42: North America – Year-over-year growth 2020-2025 (%)
• 43: Europe – Market size and forecast 2020-2025 ($ million)
• 44: Europe – Year-over-year growth 2020-2025 (%)
• 45: Asia – Market size and forecast 2020-2025 ($ million)
• 46: Asia – Year-over-year growth 2020-2025 (%)
• 47: ROW – Market size and forecast 2020-2025 ($ million)
• 48: ROW – Year-over-year growth 2020-2025 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ million)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: Abbott Laboratories – Overview
• 58: Abbott Laboratories – Business segments
• 59: Abbott Laboratories – Key offerings
• 60: Abbott Laboratories – Key customers
• 61: Abbott Laboratories – Segment focus
• 62: Agilent Technologies Inc. – Overview
• 63: Agilent Technologies Inc. – Business segments
• 64: Agilent Technologies Inc. – Key offerings
• 65: Agilent Technologies Inc. – Key customers
• 66: Agilent Technologies Inc. – Segment focus
• 67: Bio-Rad Laboratories Inc. – Overview
• 68: Bio-Rad Laboratories Inc. – Business segments
• 69: Bio-Rad Laboratories Inc. – Key offerings
• 70: Bio-Rad Laboratories Inc. – Key customers
• 71: Bio-Rad Laboratories Inc. – Segment focus
• 72: Bio-Techne Corp. – Overview
• 73: Bio-Techne Corp. – Business segments
• 74: Bio-Techne Corp. – Key offerings
• 75: Bio-Techne Corp. – Key customers
• 76: Bio-Techne Corp. – Segment focus
• 77: F. Hoffmann-La Roche Ltd. – Overview
• 78: F. Hoffmann-La Roche Ltd. – Business segments
• 79: F. Hoffmann-La Roche Ltd. – Key offerings
• 80: F. Hoffmann-La Roche Ltd. – Key customers
• 81: F. Hoffmann-La Roche Ltd. – Segment focus
• 82: Merck KGaA – Overview
• 83: Merck KGaA – Business segments
• 84: Merck KGaA – Key offerings
• 85: Merck KGaA – Key customers
• 86: Merck KGaA – Segment focus
• 87: NeoGenomics Laboratories, Inc. – Overview
• 88: NeoGenomics Laboratories, Inc. – Business segments
• 89: NeoGenomics Laboratories, Inc. – Key offerings
• 90: NeoGenomics Laboratories, Inc. – Key customers
• 91: NeoGenomics Laboratories, Inc. – Segment focus
• 92: PerkinElmer Inc. – Overview
• 93: PerkinElmer Inc. – Business segments
• 94: PerkinElmer Inc. – Key offerings
• 95: PerkinElmer Inc. – Key customers
• 96: PerkinElmer Inc. – Segment focus
• 97: QIAGEN NV – Overview
• 98: QIAGEN NV – Business segments
• 99: QIAGEN NV – Key offerings
• 100: QIAGEN NV – Key customers
• 101: QIAGEN NV – Segment focus
• 102: Thermo Fisher Scientific Inc. – Overview
• 103: Thermo Fisher Scientific Inc. – Business segments
• 104: Thermo Fisher Scientific Inc. – Key offerings
• 105: Thermo Fisher Scientific Inc. – Key customers
• 106: Thermo Fisher Scientific Inc. – Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations



【掲載企業】

Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, Thermo Fisher Scientific Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のIn situハイブリダイゼーション(ISH)市場2021-2025:FISH、CISH]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆